Acupuncture Combined With Chemotherapy for Gastric Cancer After Surgery

Prior treatment

• Those planning to receive postoperative adjuvant radiotherapy
• Those who have received acupuncture treatment within the past 6 weeks
• Fever within 3 days prior to enrollment with a temperature above 38°C or clinically significant infections(Subject to enrollment once infection is managed)
• Currently receiving or having used the investigational drug or device within 4 weeks prior to the first intervention of the study

Other illness

• History of blood system diseases, organ transplant history, or those requiring long-term oral immunosuppressants
• Individuals with implanted cardiac pacemakers
• Pregnant or breastfeeding women, individuals with mental illness, intellectual or language disabilities, those lacking legal capacity, or those whose medical or ethical reasons affect the continuation of the study

Other

• Unable to complete baseline assessment
• Individuals with a fear of acupuncture
• Presence of other primary tumors

• Patients with gastric cancer who have undergone R0 resection of the stomach/ distal stomach with D2 lymphadenectomy and are planned to receive postoperative adjuvant chemotherapy
• Postoperative pathological diagnosis of gastric cancer, with pathological staging of pII/pIII (American Joint Committee on Cancer, AJCC)
• No recurrence or metastasis confirmed by imaging examination
• Performance Status (PS) score of 0-2
• Age between 18 and 75 years
• Normal bone marrow, liver, and kidney function:
  • Normal bone marrow function: Neutrophil count ≥1.5×10\^9/L, platelet count ≥100×10\^9/L, hemoglobin ≥90g/L
  • Normal kidney function: Serum creatinine ≤1.5mg/dl (133μmol/L) and/or creatinine clearance ≥60ml/min
  • Normal liver function: Total serum bilirubin level ≤1.5 times the upper limit of normal (ULN), serum aspartate aminotransferase (AST) \& alanine aminotransferase (ALT) ≤2.5 times ULN
• Signed informed consent, and the patient voluntarily accepts treatment according to this protocol